Antiviral oligo- and polyribonucleotides containing selected triazolo[2,3-a]purines

Journal of Medicinal Chemistry

Volumn 41, Issue 25, 1998, Pages 4958-4964

  Tutonda, Mayoka G ^a   Buckheit Jr , Robert W ^b   Agrawal, Vijai K ^a,c   Broom, Arthur D ^a  

^a UNIVERSITY OF UTAH   (United States)

^b SOUTHERN RESEARCH INSTITUTE   (United States)

^c Aral Biosynthetics   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1,2,4 TRIAZOLE DERIVATIVE; 8 AMINOGUANOSINE; GANCICLOVIR; MERCAPTOPURINE RIBOSIDE; OLIGORIBONUCLEOTIDE; POLY[5 METHYL 9 OXO 3 (BETA DEXTRO RIBOFURANOSYL) 1,2,4 TRIAZOLO[2,3 A]PURINYLIC ACID; POLYRIBONUCLEOTIDE; PURINE DERIVATIVE; THIOGUANOSINE; UNCLASSIFIED DRUG; ZALCITABINE;

ANTIVIRAL ACTIVITY; ARTICLE; CONTROLLED STUDY; DRUG POTENCY; DRUG SCREENING; HUMAN; HUMAN CELL; HUMAN CYTOMEGALOVIRUS; HUMAN IMMUNODEFICIENCY VIRUS; MOLECULAR WEIGHT; STRUCTURE ACTIVITY RELATION; VIRUS INHIBITION;

ANIMALS; ANTI-HIV AGENTS; ANTIVIRAL AGENTS; CELL LINE; CYTOMEGALOVIRUS; HIV-1; HUMANS; INHIBITORY CONCENTRATION 50; MICE; OLIGORIBONUCLEOTIDES; PLAQUE ASSAY; POLYRIBONUCLEOTIDES; PURINES; STRUCTURE-ACTIVITY RELATIONSHIP; VIRUS REPLICATION;

EID: 0032481060     PISSN: 00222623     EISSN: None     Source Type: Journal    
DOI: 10.1021/jm9802057     Document Type: Article

References (21)

1. Mertens, T. E.; Low-Beer, D. HIV and AIDS: where is the epidemic going? Bull WHO 1996, 74 (2), 121-129.
2. Fischl, M. A.; Richman, D. D.; Grieco, M. H.; Gottlieb, M. S.; Volberding, P. A.; Laskin, O. L.; Leedom, J. M.; Groopman, J. E.; Mildvan, D.; Schooley, R. T.; Jackson, G. G.; Durack, D. T.; King, D. The efficacy of azidothymidine (AZT) in the treatment of patients with AIDS and AIDS-related complex. N. Engl. J. Med. 1987, 377, 185-191.
3. Yarchoan, R.; Thomas, R. V.; Allain, J. P.; McAtee, N.; Dubinsky, R.; Mitsuya, H.; Lawley, T. J.; Safai, B.; Myers, C. E.; Perno, C. F.; Klecker, R. W.; Wills, R. J.; Fischl, M. A.; McNeely, M. C.; Pluda, J. M. L.; Leuther, M.; Collins, J. M.; Broder, S. Phase I studies of 2′,3′-dideoxycytidine in severe human immunodeficiency virus infection as a single agent and alternative with AZT. Lancet 1988, I, 76-81.
4. Cooley, T. P.; Kunches, L. M.; Saunders, C. A.; Ritter, J.; Perkins, C. J.; McLaren, C.; Path, M. R. C.; McCaffrey, R. P.; Liebman, H. A. Once-daily administration of 2′,3′-dideoxyinosine (ddI) in patients with the acquired immunodeficiency syndrome or AIDS-related complex. N. Engl. J. Med. 1990, 322, 1340-1345.
5. Staszewski, S.; Hill, A. M.; Bartlett, J.; Eron, J. J.; Katlana, C.; Johnson, J.; Sawyer, W.; McDade, H. Reductions in HIV-1 Disease Progression for Zidovudine Lamivudine Relative to Control Treatments. AIDS 1997, 11, 477-83.
6. Mathe, G.; Colasante, V.; Morette, C.; Hallard, M.; Blanquet, D. Will killing the last HIV-1 particle cure AIDS patients? Biomed. Pharmacother. 1996, 50, 473-479.
7. Craig, C.; Moyle, G. The development of resistance of HIV-1 to zalcitabine. AIDS 1997, 11, 271-279.
8. Iversen, A. K. N.; Shafer, R. W.; Wehrly, K.; Winters, M. A.; Mullins, J. I.; Chesebro, B.; Merigan, T. Multidrug-resistant human immunodeficiency virus type 1 strains resulting from combination antiretroviral therapy. J. Virol. 1996, 70 (2), 1086-1090.
9. Katlama, C. Consequences for the management of cytomegalovirus. AIDS 1996, 10, 543-546.
10. Engstrom, R. E.; Holland, G. N. Local therapy for cytomegalovirus retinopathy. Am. J. Ophthalmol. 1995, 120 (3), 376-385.
11. Broom, A. D.; Agrawal, V. K.; Tutonda, M. G.; Fain, H. D.; Buckheit, R. W. Unusual single-stranded polyribonucleotides as potent anti-HIV agents. J. Med. Chem. 1995, 38, 3253-3257.
12. Tutonda, M. G.; Fain, H. D.; Buckheit, R. W.; Broom, A. D. The role of hydrophobic versus hydrophilic base character in the antiHIV activity of purine-containing polyribonucleotides. Nucleosides Nudeotides 1997, 16 (1&2), 173-182.
13. Anderson, G. L.; Rizkalla, B. H.; Broom, A. D. Synthesis of some tricyclic nucleosides related to the "Y" base of tRNA. J. Org. Chem. 1974, 39, 937-939.
14. Gilchrist, T. L. Heterocyclic Chemistry, 2nd ed.; John Wiley & Sons: New York, 1992; p 286.
15. Ueda, T.; Boryski, J. Synthesis from Guanosine via 4-Demethylwyosine. In Nucleic Acid Chemistry, Part 4; Townsend, L. B., Tipson, R. S., Eds.; John Wiley & Sons: New York, 1991; pp 248-251.
16. Yoshikawa, M.; Kato, T.; Takenishi, T. Studies of Phosphorylation III. Selective phosphorylation of unprotected nucleosides. Bull. Chem. Soc. Jpn. 1969, 42, 3505-3508.
17. Hoard, D. E.; Ott, D. G. Conversion of Mono- and Oligodeoxyribonucleotides to 5′-Triphosphates. J. Am. Chem. Soc. 1965, 87, 1785-1788.
18. Yano, J.; Kan, L. S.; Ts'o, P. O. P. A simple method of the preparation of 2′-O-Methyladenosine -Methylation of adenosine with methyl iodide in anhydrous alkaline medium. Biochim. Biophys. Acta 1980, 629, 178-183.
19. Robins, M. J.; Wilson, J. S.; Sawyer, L.; James, M. N. G. Nucleic acid related compounds. 41. Restricted furanose conformations of 3′,5′-O-(1,1,3,3,-tetraisopropyldisilox-1,3-diyl)nucleosides provide a convenient evaluation of anomeric configuration. Can. J. Chem. 1983, 61, 1911-1920.
20. Kierzek, R.; Caruthers, M. H.; Longfellow, C. E.; Swinton, D.; Turner, D. H.; Freier, S. M. Polymer-Supported RNA Synthesis and its application to test the nearest-neighbor model for duplex stability. Biochemistry 1986, 25, 7840-7846.
21. Huffman, J. H.; Sidwell, R. W.; Morrison, A. G.; Coombs, J.; Reist, E. J. Structure-activity relationship of phosphonic acid analogues of acyclovir or ganciclovir against human cytomegalovirus in MRC-5 cells. Nucleosides Nucleotides 1994, 13 (1-3), 607-613.